Article Image
IPFS News Link • Science, Medicine and Technology

MS drug treatment shows promise

• AP
Novartis Pharmaceuticals Corp., the U.S. unit of Swiss drugmaker Novartis AG said that at least three out of four patients given an experimental multiple sclerosis treatment were free of relapses for more than two years.